Literature DB >> 29528686

Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.

Josef R Bober1, Chase L Beisel2, Nikhil U Nair1.   

Abstract

An increasing number of studies have strongly correlated the composition of the human microbiota with many human health conditions and, in several cases, have shown that manipulating the microbiota directly affects health. These insights have generated significant interest in engineering indigenous microbiota community members and nonresident probiotic bacteria as biotic diagnostics and therapeutics that can probe and improve human health. In this review, we discuss recent advances in synthetic biology to engineer commensal and probiotic lactic acid bacteria, bifidobacteria, and Bacteroides for these purposes, and we provide our perspective on the future potential of these technologies.

Entities:  

Keywords:  CRISPR; genetic tools; genome engineering; microbiome; probiotics

Mesh:

Substances:

Year:  2018        PMID: 29528686      PMCID: PMC6100750          DOI: 10.1146/annurev-bioeng-062117-121019

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  145 in total

1.  Heterologous protein secretion by Lactobacillus plantarum using homologous signal peptides.

Authors:  G Mathiesen; A Sveen; J-C Piard; L Axelsson; V G H Eijsink
Journal:  J Appl Microbiol       Date:  2008-02-20       Impact factor: 3.772

Review 2.  Evolutionary Ecology of Prokaryotic Immune Mechanisms.

Authors:  Stineke van Houte; Angus Buckling; Edze R Westra
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-13       Impact factor: 11.056

3.  Factors influencing the composition of the intestinal microbiota in early infancy.

Authors:  John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

4.  Heterologous surface display on lactic acid bacteria: non-GMO alternative?

Authors:  Petra Zadravec; Borut Štrukelj; Aleš Berlec
Journal:  Bioengineered       Date:  2015-04-16       Impact factor: 3.269

Review 5.  Current advances in humanized mouse models.

Authors:  Ryoji Ito; Takeshi Takahashi; Ikumi Katano; Mamoru Ito
Journal:  Cell Mol Immunol       Date:  2012-02-13       Impact factor: 11.530

6.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.

Authors:  Robert J Citorik; Mark Mimee; Timothy K Lu
Journal:  Nat Biotechnol       Date:  2014-09-21       Impact factor: 54.908

7.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Authors:  David Bikard; Chad W Euler; Wenyan Jiang; Philip M Nussenzweig; Gregory W Goldberg; Xavier Duportet; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2014-10-05       Impact factor: 54.908

Review 8.  Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches.

Authors:  José E Belizário; Mauro Napolitano
Journal:  Front Microbiol       Date:  2015-10-06       Impact factor: 5.640

9.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

Review 10.  Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications.

Authors:  C Michon; P Langella; V G H Eijsink; G Mathiesen; J M Chatel
Journal:  Microb Cell Fact       Date:  2016-05-03       Impact factor: 5.328

View more
  26 in total

Review 1.  Development of bacteria as diagnostics and therapeutics by genetic engineering.

Authors:  Daejin Lim; Miryoung Song
Journal:  J Microbiol       Date:  2019-05-11       Impact factor: 3.422

Review 2.  Engineering microbial diagnostics and therapeutics with smart control.

Authors:  Matthew B Amrofell; Austin G Rottinghaus; Tae Seok Moon
Journal:  Curr Opin Biotechnol       Date:  2020-06-18       Impact factor: 9.740

3.  A Tunable and Expandable Transactivation System in Probiotic Yeast Saccharomyces boulardii.

Authors:  Suryang Kwak; Bejan Mahmud; Gautam Dantas
Journal:  ACS Synth Biol       Date:  2021-12-23       Impact factor: 5.249

4.  Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.

Authors:  Fu-Chen Huang; Yi-Ting Lu; Yu-Hsuan Liao
Journal:  Innate Immun       Date:  2020-09-28       Impact factor: 2.680

5.  Genetic Manipulation of Wild Human Gut Bacteroides.

Authors:  Natasha A Bencivenga-Barry; Bentley Lim; Carmen M Herrera; M Stephen Trent; Andrew L Goodman
Journal:  J Bacteriol       Date:  2020-01-15       Impact factor: 3.490

6.  Quantifying and Engineering Mucus Adhesion of Probiotics.

Authors:  Zachary J S Mays; Todd C Chappell; Nikhil U Nair
Journal:  ACS Synth Biol       Date:  2020-01-13       Impact factor: 5.110

7.  A quantitative model for metabolic intervention using gut microbes.

Authors:  Zachary J S Mays; Nikhil U Nair
Journal:  Biotechnol Prog       Date:  2021-01-16

Review 8.  Gut microbiome, liver immunology, and liver diseases.

Authors:  Rui Wang; Ruqi Tang; Bo Li; Xiong Ma; Bernd Schnabl; Herbert Tilg
Journal:  Cell Mol Immunol       Date:  2020-12-14       Impact factor: 11.530

9.  In vitro fermentation test bed for evaluation of engineered probiotics in polymicrobial communities.

Authors:  Steven Arcidiacono; Amy M Ehrenworth Breedon; Michael S Goodson; Laurel A Doherty; Wanda Lyon; Grace Jimenez; Ida G Pantoja-Feliciano; Jason W Soares
Journal:  J Biol Methods       Date:  2021-05-26

Review 10.  Epithelial wound healing in inflammatory bowel diseases: the next therapeutic frontier.

Authors:  Cambrian Y Liu; Candace M Cham; Eugene B Chang
Journal:  Transl Res       Date:  2021-06-12       Impact factor: 10.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.